@article{48bba5c1a8774dc4b0a2c8e136a7e6f7,
title = "A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?",
author = "Alessandro Leonetti and Daniela Carbone and Alessandro Gregori and Marcello Tiseo and Peters, {Godefridus J.} and Dongmei Deng and Elisa Giovannetti",
note = "Funding Information: MT has been on advisory boards and received speakers{\textquoteright} fees for Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis, Roche, MSD, Boehringer Ingelheim, Otsuka, Takeda, and Pierre Fabre. MT has received research grants from Astra-Zeneca and Boehringer Ingelheim. AL received speakers{\textquoteright} fees for Astra-Zeneca. Funding Information: AL and MT are supported by the AIRC-IG grant# 20,074, AG and EG are supported by the KWF Grant#19,571, GJP and EG are supported by the Polish National Science Center Grant#2018/31/B/NZ7/02,909, DD and EG are supported by Cancer Center Amsterdam Grants 2016 and 2018, EG is supported by the AIRC-IG grant#24,444. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = oct,
doi = "10.1007/s00432-021-03647-x",
language = "English",
volume = "147",
pages = "3135--3137",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "10",
}